Frontier Bio Corp
New Filing
CIK: 0002107814·Biotechnology·DELAWARE·Filed: Nov 10, 2026
Total Offering
$1,000,000
Amount Sold
$380,000
Investors
6
First Sale
Oct 27, 2026
Offering Details
- Type
- Other: Simple Agreement for Future Equity (SAFE), convertible into preferred stock
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Eric Bennett | Related Person |
| Matthew Shore | Related Person |
| Terrence McKenna | Related Person |
Company
SEC Filing
0002107814-26-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free